semaglutide compounding fda enforcement news Compound versions of GLP-1 drugs for weight loss halted by Diabetes advocacy group discourages use

It is an authorised copy made by the original manufacturer, intended to offer the same expected benefits at a more affordable price

Key examples: Diabetes + CKD = diabetic CKD (E11.22) no explicit caused by diabetes statement needed Diabetes + neuropathy = diabetic neuropathy (E11.4x) Diabetes + retinopathy = diabetic retinopathy (E11.3xx) Diabetes + periodontal disease = diabetic periodontal disease (E11.630) However, the provider must not document that the condition is NOT related to diabetes

Treatment strategies targeting excess hippocampal activity benefit aged rats with cognitive impairment

Both semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) may cause nausea though individual patient experiences vary

This can stall your progress and lead to weight regain, potentially making the overall journey longer and less successful